BETHANY GLOTFELTY: Open Payments
NPI 1356394241 · DURANGO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 25 payments from 6 companies in 2025. Trend: 2023 $247 · 2024 $634 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $443 |
| Lilly USA, LLC | 3 | $215 |
| Regeneron Healthcare Solutions, Inc. | 4 | $169 |
| Janssen Biotech, Inc. | 3 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Madrigal Pharmaceuticals | 1 | $14 |
Products named: RINVOQ, OMVOH, SKYRIZI, DUPIXENT, TREMFYA, CREON, LINZESS, ENTYVIO.
Industry payments across CO — which companies pay providers there.
